Hacker News new | ask | show | jobs
by unmei 4747 days ago
I guess my question is, do they still have a patent on any BRCA1/2 cDNA or only that specifically created according to their method?
1 comments

According to the ruling, their patent specifies a sequence of nucleotides of cDNA independent of any method used to create them. I read that to mean that any BRCA1 or BRCA2 cDNA that matches that exact sequence would be infringing on Myriad's patent, regardless of how it was created.